{"cluster": 69, "subcluster": 14, "abstract_summ": "Data also suggest that cancer patients are particularly vulnerable, but differences between tumor entities and cancer treatments may exist.In this document, we briefly share the strategies and actions for patients with locally advanced rectal cancer to face the challenges of Coronavirus disease 2019 (COVID-19).\u2022 Metronomic therapy is a good option for locally advanced oral cancers in COVID-19 pandemic time.\u2022 Minimizing patient visits to hospitals and cancer clinics may help mitigate the spread of SARS-CoV-2.The risk/benefit ratio of a number of palliative and (neo)adjuvant treatments should be reconsidered during the COVID-19 pandemic.This letter to the editor alerts oncologists to the importance of accurately defining benefit\u2010risk ratio during the COVID\u201019 pandemic for patients with advanced\u2010stage cancer treated with chemotherapy after failure of first\u2010line and second\u2010line therapy.As COVID\u201019 the disease caused by SARS\u2010CoV\u20102 continues to have a profound impact on global health, there have been a number of guidelines recently published addressing the management of patients with liver disease during the COVID\u201019 pandemic including the recently published EASL\u2010ESCMID Position Paper, guidelines issued by the International Liver Cancer Association and the American Association for the Study of Liver Diseases (1\u20103).", "title_summ": "Treatment approach in locally advanced rectal cancer during Coronavirus (COVID-19) pandemic: long course or short course?Oral Cancer Surgery and COVID pandemic \u2013 Metronomic Therapy shows a promising role while awaiting surgeryManagement of Hepatocellular Cancer in the time of SARS\u2010CoV\u20102COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapiesAdvice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 PandemicManagement of patients with ovarian cancer in the COVID\u201019 eraCancer and COVID-19 \u2014 potentially deleterious effects of delaying radiotherapyEstimated effect of COVID\u201019 lockdown on melanoma thickness and prognosis: a rate of growth modelCOVID\u201019 in a melanoma patient under treatment with checkpoint\u2010inhibitionRadiotherapy for pain relief from bone metastases during Coronavirus (COVID\u201019) pandemicCaring for Patients with Advanced Stage Cancer at the Time of COVID\u201019Advanced renal cell carcinoma and COVID-19 \u2014 a personal perspective", "title_abstract_phrases": "Treatment approach in locally advanced rectal cancer during Coronavirus (COVID-19) pandemic: long course or short course?In this document, we briefly share the strategies and actions for patients with locally advanced rectal cancer to face the challenges of Coronavirus disease 2019 (COVID-19).Oral Cancer Surgery and COVID pandemic \u2013 Metronomic Therapy shows a promising role while awaiting surgery\u2022 Metronomic therapy is a good option for locally advanced oral cancers in COVID-19 pandemic time.Data also suggest that cancer patients are particularly vulnerable, but differences between tumor entities and cancer treatments may exist.\u2022 Minimizing patient visits to hospitals and cancer clinics may help mitigate the spread of SARS-CoV-2.Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 PandemicThe risk/benefit ratio of a number of palliative and (neo)adjuvant treatments should be reconsidered during the COVID-19 pandemic.Management of Hepatocellular Cancer in the time of SARS\u2010CoV\u20102As COVID\u201019 the disease caused by SARS\u2010CoV\u20102 continues to have a profound impact on global health, there have been a number of guidelines recently published addressing the management of patients with liver disease during the COVID\u201019 pandemic including the recently published EASL\u2010ESCMID Position Paper, guidelines issued by the International Liver Cancer Association and the American Association for the Study of Liver Diseases (1\u20103).Caring for Patients with Advanced Stage Cancer at the Time of COVID\u201019This letter to the editor alerts oncologists to the importance of accurately defining benefit\u2010risk ratio during the COVID\u201019 pandemic for patients with advanced\u2010stage cancer treated with chemotherapy after failure of first\u2010line and second\u2010line therapy."}